|
||||
|
||||
The Loss Causation Requirement for Rule 10b-5 Causes-of-Action: The Implication of Dura Pharmaceuticals v. Broudo
Allen Ferrell Harvard Law School; European Corporate Governance Institute (ECGI) Atanu Saha Compass Lexecon, New York August 2007 Harvard Law and Economics Discussion Paper No. 596 Abstract: In order to have recoverable damages in a Rule 10b-5 action, plaintiffs must establish loss causation, i.e. that the actionable misconduct was the cause of economic losses to the plaintiffs. The requirement of loss causation has come to the fore as the result of the Supreme Court's landmark decision in Dura Pharmaceuticals v. Broudo. We address in this paper a number of loss causation issues in light of the Dura decision, including issues surrounding the proper use of event studies to establish recoverable damages, the requirement that there be a corrective disclosure, what types of disclosure should count as a corrective disclosure, post-corrective disclosure stock price movements, the distinction between the class period and the damage period, collateral damage caused by a corrective disclosure, and forward-casting estimates of recoverable damages.
Keywords: Securities damages, Dura, Dura Pharmaceuticals, Broudo, securities litigation, Rule 10b-5, event study, securities regulation, loss causation JEL Classifications: K22, K42 Working Paper SeriesDate posted: August 16, 2007 ; Last revised: November 04, 2008Suggested CitationContact Information
|
|
||||||||||||||||
© 2010 Social Science Electronic Publishing, Inc. All Rights Reserved.
FAQ
Terms of Use
Privacy Policy
Copyright
This page was served by apollo5b in 0.344 seconds.